The Dermatology Digest

JANUARY 16, 2024

Food and Drug Administration (FDA) has updated the label for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc. and Sanofi), adding efficacy and safety data for people aged 12 years and older with atopic dermatitis (AD) and uncontrolled moderate-to-severe hand and/or foot involvement. and Sanofi report. “We

Dermatitis 36

Dermatitis Pharmaceutical Safety Dermatology 36

The Dermatology Digest

MAY 2, 2024

Aslan and Zenyaku are teaming up to explore how eblasakimab’s mechanism of action differs from that of other biologic therapies for atopic dermatitis (AD). This new agreement expands upon the commercial agreement that Aslan signed with Zenyaku in June 2023 for the development and commercialization of eblasakimab in Japan.

Pharmaceutical 74

Pharmaceutical Dermatitis Office Clinic 74

The Dermatology Digest

MARCH 11, 2024

Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

The Dermatology Digest

APRIL 22, 2024

Adult atopic dermatitis (AD) patients previously treated with dupilumab (Dupixent, Regeneron and Sanofi) who received 400mg eblasakimab weekly achieved Eczema Area Severity Index (EASI) 90, and 66.7% Treatment was well-tolerated and no new safety signals were identified.

Pharmaceutical 36

Pharmaceutical Dermatitis Eczema Injections 36

The Dermatology Digest

MARCH 11, 2024

Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 13, 2024

Genodermatoses can masquerade as atopic dermatitis (AD). Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Think Twice: Is It Really AD?

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 11, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

First Derm

DECEMBER 26, 2023

Consult Healthcare Providers When Necessary : Seek professional advice for persistent, severe, or unusual scalp symptoms to ensure accurate diagnosis and effective treatment. Dandruff (Seborrheic Dermatitis) Dandruff, medically known as seborrheic dermatitis , is a common scalp condition marked by excessive shedding of skin cells.

Management 64

Management Dermatitis Eczema Consultations 64

The Dermatology Digest

MARCH 13, 2024

Single-cell profiling of alopecia areata (AA) can provide key insights into immune-targeting treatment strategies. Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Watch Now Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD).

Dermatitis 36

Dermatitis Dermatology Clinic Skin Issues 36

The Dermatology Digest

MARCH 14, 2024

Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University in New Haven, CT, shares some congenital ichthyosis (CI) cases and discusses the importance of understanding patient and family expectations about CI treatment.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Chronic spontaneous urticaria (CSU) often has no identifiable trigger and is driven by mast cells, but symptoms are bothersome to patients, highlighting the need for effective treatments, says Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Watch Now [the_ad id="9263"] [the_ad id="9265"] Pro Pearls for Diagnosing Genodermatoses Elizabeth Swanson, MD Genodermatoses can masquerade as atopic dermatitis (AD). Elizabeth (Lisa) Swanson, MD, a pediatric dermatologist in Boise, ID, shares three pearls on how to make these important differential diagnoses.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Watch Now Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo Emma Guttman-Yassky, MD, PhD Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes. Watch Now The Lowdown on Molluscum Nanette B.

Dermatitis 28

Dermatitis Dermatology Eczema Clinic 28

The Dermatology Digest

DECEMBER 15, 2023

AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. In a second study, treatment with ruxolitinib cream under maximum-use conditions was well tolerated in same-aged kids for eight weeks.

Dermatology 36

Dermatology Pharmaceutical Clinic Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. In a second study, treatment with ruxolitinib cream under maximum-use conditions was well tolerated in same-aged kids for eight weeks.

Dermatology 36

Dermatology Pharmaceutical Clinic Therapy 36

Aesthetics Advisor

AUGUST 22, 2023

In this era of readily available pharmaceutical products for every imaginable ailment, it can be easy to default to the drug store when we need relief. Medieval Persian pharmaceutical manuscripts refer to 1200 types of oxymel. It has not always been that way. Reposted from: [link]

Extractions 36

Extractions Pharmaceutical Diet Ingredients 36

First Derm

FEBRUARY 21, 2024

There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision. A dermatologist can provide personalized recommendations and treatment plans tailored to your child’s specific needs.

Retinol 104

Retinol Social Media Skincare Routine Skincare 104

The Dermatology Digest

FEBRUARY 12, 2024

Alys Pharmaceuticals, Inc. Alys combines six asset-centric Medicxi companies including Al Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics. ” The post Get to Know Alys Pharmaceuticals, Inc. appeared first on The Dermatology Digest.

Pharmaceutical 74

Pharmaceutical Technology Dermatology Medical 74

First Derm

OCTOBER 28, 2021

Over the years, retinol has been touted as the holy grail anti-aging treatment by almost every dermatologist and skin care expert…it is often recommended as the “must-have” active ingredient in your skin care routine. Bakuchiol – Vegan Retinol – What is all the hype about?

Retinol 52

Retinol Sensitive Skin Anti-Aging Treatment Skin Types 52

Aesthetics Advisor

MARCH 15, 2024

Here’s a review of 10 natural antimicrobials you can reach for as a first line of defense, before resorting to a pharmaceutical antibiotic. Department of Health proposed guidelines recommending the use of honey as a first line of treatment for coughs, as part of its goal to reduce inappropriate antibiotic use. In 2018, the U.K.

Extractions 36

Extractions Medical Treatments Irritation 36

The Dermatology Digest

AUGUST 4, 2023

Elisabeth Richard discusses phototherapy in today’s practice, including usage trends, its continued role in the treatment of numerous skin diseases, and the importance of continuing to offer it to patients as a therapeutic option. When I’m counseling patients I tell them a clearance course is typically about 25 to 30 treatments.

Eczema 36

Eczema Private Practice Therapy Dermatitis 36